FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.

Name: FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.
Published: 2026
License: Public Domain

Jiangsu HengRui Medicine Co., Ltd. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

locally advanced, recurrent or metastatic escc patients who have failed prior pd-1/pd-l1 inhibitors combined with platinum-based chemotherapy, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

FH-006 Versus Investigator's Choice of Chemotherapy in Patients With Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma Who Have Failed Prior PD-1/PD-L1 Inhibitor Combined With Platinum-Based Chemotherapy.

Related documents